Celldex Therapeutics
CLDX
#4620
Rank
โ‚น199.65 B
Marketcap
โ‚น2,542
Share price
-1.90%
Change (1 day)
15.28%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): -โ‚น398.78

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น403.11. In 2025 the company made an earnings per share (EPS) of -โ‚น360.49 a decrease over its 2024 EPS that were of -โ‚น227.04.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น398.7810.62%
2025-โ‚น360.4958.78%
2024-โ‚น227.04
2022-โ‚น221.4845.73%
2021-โ‚น151.98-23.36%
2020-โ‚น198.31-41.05%
2019-โ‚น336.39-76.95%
2018-โ‚น1,460
2016-โ‚น1,751-3.82%
2015-โ‚น1,821-0.76%
2014-โ‚น1,835
2012-โ‚น1,418

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.80-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,611-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น266.64-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-โ‚น406.82 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚น371.61-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น187.19-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น467.06 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA